Breakthroughs in Immunity

Stem cell therapy to treat COVID-19 with Dr. Bob Hariri and Dr. Peter Diamandis

Posted by: Team Tony

Select Your Preferred Platform

If you are like many people, you’re trying to make sense of all the information about coronavirus that is being shared 24 hours a day on television, headline news, and across social media channels around the world.

It’s a lot to keep up with and comprehend as new numbers and statistics about COVID-19 are being broadcast around the clock. In this episode, we’re bringing you two long-time, leading physicians to provide context and clarification of the facts.

Dr. Peter Diamandis and Dr. Bob Hariri will break down the coronavirus data you’re seeing and hearing from the media. Dr. Hariri, a surgeon, biomedical scientist and serial entrepreneur in biomedical technology will also share some of his team’s breakthroughs in a stem cell treatment that could prove to be an effective solution for COVID-19.

This interview was recorded Thursday, April 9.

Listen to Part 2 here.

EPISODE NOTES

[00:15] Text Tony on Community
[01:00] Providing context
[01:30] Dr. Hariri
[02:00] Second opinion
[02:30] Breakthroughs
[03:00] Intro Peter Diamandis
[03:30] What’s available?
[04:00] Cellular medicine
[04:30] Testing
[05:00] Accelerated vaccine
[05:30] Tony intros Bob Hariri
[06:00] Tony’s rotator cuff
[06:30] Bob’s background
[07:00] Let’s start with context
[07:30] What’s unique
[08:00] Early evaluation
[08:30] Unusual reports
[09:00] Incubation rates
[09:30] Exposure
[10:00] Mild vs. severe
[10:30] The numbers
[11:00] Original fatality rate
[11:30] Crisis-call
[12:00] Familiarity with the flu
[12:30] Algorithms
[13:00] Bad data in, bad data out
[13:30] New England Journal of Medicine
[14:00] Dr. Fauci renounces earlier numbers
[14:30] Early predictions
[15:00] Basis for panic response
[15:30] Swabbing and measuring
[16:00] Colonization
[16:30] Not an accurate reflection
[17:00] Two graphs
[17:30] Lies, damn lies, and statistics
[18:00] Pandemic of fear
[18:30] Global deaths daily
[19:00] Silver lining
[19:30] “Practice pandemic”
[20:00] Uncovered all breakpoints
[20:30] Progress with the FDA
[21:00] Pre-existing conditions
[21:30] Sensitive tests
[22:00] 600% jump
[22:30] Fair representation
[23:00] 2014 article
[23:30] Fitting the narrative
[24:00] Flatten the curve
[24:30] 12 hours in the ER
[25:00] Bob’s discovery as a father
[25:30] Threshold for intervention
[26:00] Immunity
[26:30] Those in the hospital
[27:00] Lungs at altitude
[27:30] Lung damage
[28:00] Ventilators
[28:30] Airway pressure
[29:00] Attention to the immune system
[29:30] Hurricane analogy
[30:00] Heavy assignment
[30:30] This requires more heads than one
[31:00] Slowing community immunity
[31:30] A taxed healthcare system
[32:00] The repercussions of solation
[32:30] Optimism
[33:00] How do we revitalize?
[33:30] Part of the environment
[34:00] Ohio’s example
[34:30] Sweden’s approach
[35:00] Conservative measures
[35:30] Younger people
[36:00] People won’t change the channel
[36:30] We need to engage others
[37:30] Solutions
[38:00] Car accidents
[38:30] More faith than we think
[39:00] Breakthroughs in regenerative medicine
[39:30] Preventing this from happening again
[40:00] Augmenting immunity
[40:30] Tony’s new book
[41:00] It started with rats
[41:30] Blood vessels
[42:00] Stem cell biology
[42:30] Ultrasound
[43:00] Nature’s stem cell factory
[43:30] Bob’s company
[44:00] Defense capabilities
[44:30] Defending offspring
[45:00] Unique natural killer cell
[45:30] Targeting
[46:00] Granted permission
[46:30] How sick are these patients?
[47:00] China’s treatments
[47:30] Revolutionary treatment
[48:00] Reinforcements
[48:30] Supplementing
[49:00] How is this scalable?
[49:30] A whole lot of placenta
[50:00] Efficiencies are increasing
[50:30] Stem cell banking
[51:00] Growing organs
[51:30] LifebankUSA
[52:00] Age correlation
[52:30] Preparation for future challenges
[53:00] Life-saving products
[53:30] Rational form of support
[54:00] Rearing its ugly head
[54:30] One size fits all approach
[55:00] We are open to new ideas
[55:30] Great innovation
[56:00] Hydroxychloroquine
[56:30] Dismissing promising therapies
[57:00] Mapping of COVID-19
[57:30] Lupus correlation
[58:00] Regulatory communities
[58:30] Medical judgements
[59:00] Did we dissuade people?
[59:30] Extra margin of protection
[1:00:00] One opinion
[1:00:30] Global aim
[1:01:00] The early trickle
[1:01:30] Experimenting
[1:02:00] Hold hope
[1:02:30] Peter’s background
[1:03:00] Stream analogy
[1:03:30] Know the road ahead
[1:04:00] Psychology of crisis
[1:04:30] Short term pain yields long term gain
[1:05:00] All about the immune system
[1:05:30] Transform the tools
[1:06:00] Nature’s repair kit
[1:06:30] Cellularity’s process
[1:07:00] Fountain Life
[1:07:30] How do we deliver?
[1:08:00] Orthopedic advances
[1:08:30] The next generation
1:09:00 The wild west
1:09:30 Impact of stem cells
1:10:00 The source determines the potency
1:10:30 Working to demonstrate
1:11:00 Consistency
1:11:30 Prime time
1:12:00 Reputable groups
1:12:30 Source matters
1:13:00 Solutions surge
1:13:30 Massive rebound
1:14:00 A time to be inventive
1:14:30 Reason for hope and optimism
1:15:00 Let’s spring forward together
1:15:30 Thank you Peter and Bob

 

About Dr. Bob Hariri

Bob Hariri is a surgeon, biomedical scientist and highly successful serial entrepreneur in two technology sectors: biomedicine and aerospace. As founder and CEO of Celularity, one of the world’s largest human cellular therapeutics companies, Dr. Hariri has pioneered the use of stem cells to treat a range of life threatening diseases and has made transformative contributions in the field of tissue engineering. His activities and experience includes academic neurosurgeon at Cornell, businessman, military surgeon and aviator and aerospace innovator. Dr. Hariri has over 90 issued and pending patents, has authored over 100 published chapters, articles and abstracts and is most recognized for his discovery of pluripotent stem cells from the placenta.

 

About Dr. Peter Diamandis

Peter Diamandis is Chairman and CEO of the X PRIZE Foundation, best known for its $10 million Ansari X PRIZE for private spaceflight. Today the X PRIZE leads the world in designing and operating large-scale global competitions to solve market failures. Diamandis is also the Co-Founder and Vice-Chairman of Human Longevity Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy human lifespan. He is also the Co-Founder and Executive Chairman of Singularity University, a graduate-level Silicon Valley institution that studies exponentially growing technologies, their ability to transform industries and solve humanity’s grand challenges.